OPTI 522 Contrast Agents, Molecular Imaging, and Kinetics

Current topics in drug discovery and molecular imaging involve the integration of a series of research modalities. The pharmaceutical Industry uses these modalities in their developmental and regulatory efforts to attain new indications. As well, the medical device community is continually developing new techniques to enhance medical imaging for the earliest detection of disease. Furthermore, kinetic ADME studies (absorbtion, distribution, metabolism, and excretion) are required so as to determine the fate of these agents as an indicator of efficacy and toxicity.